Stay updated on TRINITY Study Clinical Trial
Sign up to get notified when there's something new on the TRINITY Study Clinical Trial page.

Latest updates to the TRINITY Study Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe ClinicalTrials.gov page now displays the study record for the rovalpituzumab tesirine trial, including its eligibility criteria, outcomes, and study documents, in place of a 403 error page.SummaryDifference52%

- Check16 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check23 days agoChange DetectedA sitewide banner announces an NIH terminology transition, saying agencies are replacing “Artificial Intelligence” with “Super Intelligence” and linking to updates and FAQs.SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov study page, which continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer revision identifier is updated from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check57 days agoChange DetectedThe TRINITY study page now shows a 403 Forbidden error, replacing the usual study details with an error page.SummaryDifference19%

Stay in the know with updates to TRINITY Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TRINITY Study Clinical Trial page.